The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

3 Jan 2012 07:00

RNS Number : 8394U
ViaLogy PLC
03 January 2012
 



ViaLogy PLC ("ViaLogy" or "the Company")

 

Business update

 

Pasadena, January 3, 2012. ViaLogy PLC (VIY LSE/AIM), a provider of reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas Exploration and Production companies based on proprietary, patented active signal processing technology, reports substantial progress has been achieved in consolidating relationships with major oil and gas exploration companies on three continents during the last quarter of 2011. In Asia, a contract with a National Oil Company awaits government approval to transfer seismic information before it is signed. In the US, a pilot contract with a supermajor has been completed and acknowledged as positive by the client, and for a large independent exploration company a blind test determined porosity features across a 60 sq km prospect in Texas. In Europe, at the invitation of another supermajor, ViaLogy scientists briefed over 50 company geophysicists around the world on QuantumRD, its powerful computational weak signal processing technology which aids the discovery, characterization, and sizing of hydrocarbon deposits.

In updating the Company's progress to bring the technology to the attention of the O&G giants, CEO Robert W. Dean acknowledges that there have been time frustrations beyond ViaLogy's control; "Unforeseen delays unrelated to our work have affected the consummation of contracts," he said.

In Asia, ViaLogy expects contract awards from two global E&P companies. The first such contract, with a National Oil Company, the contract award process has been dictated by standard procedures and timelines already in place for work performed on government leased fields. Now, however, negotiations have been concluded and contract terms agreed. The final phase involves obtaining approval from the government for the export of seismic data to ViaLogy's US headquarters in Pasadena. In the second case, many similar rules apply both to leaseholder and ViaLogy, but the ViaLogy board believe that the contract process is now on track to award.

In the US, results from ViaLogy's pilot contract for its current supermajor client have been acknowledged as positive and have presented results and conclusions on porosity values that would be unattainable with technology now in use by the client. Their quantitative analysis continues, and should result in further contract work under our already-signed Master Services Agreement.

Another ViaLogy success, this one for a large US-based independent, determined porosity features across a 60 sq km prospect in Texas. In this blind test of the technology porosity values were determined in five Permian formations using seismic data from which other analysis techniques had been unable to extract this information. The client confirms this and is conducting further quantitative evaluation. Accurate predictions of porosity are fundamental in identifying hydrocarbon locations, and a measure of QuantumRD's ability to add breakthrough value in the seismic analysis industry.

Involvement in Europe resulted from an unsolicited approach to ViaLogy by a second supermajor in September. Now detailed technical examination is underway and has been ongoing for over three months. The process has extended to multiple locations, and the supermajor has engaged its most senior technical and scientific staff, as well as its operational management.

"Running this gauntlet of rigorous technical scrutiny takes time and concentration, but is at the heart of client recruitment for us in this 'big tent' part of the industry. It will serve ViaLogy well going forward, and should result in contracted project work," said Mr. Dean.

 

 

For further information:

 

ViaLogy PLC

Terry Bond, Chairman - UK & Europe +44 (0) 1235 834 734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 207 107 8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery.

ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABLGDBIBGBGDD
Date   Source Headline
15th May 20187:00 amRNSYear-end Trading Update and £2.5m Fundraising
30th Apr 20184:00 pmRNSNotice of Trading Update
29th Mar 20187:00 amRNSPremaitha to attend industry conferences in APAC
26th Mar 20187:00 amRNSUpdate on UK patent infringement claim
16th Feb 20187:00 amRNSPremaitha secures market entry into Egypt
14th Feb 201810:25 amRNSHolding(s) in Company
12th Feb 20187:00 amRNSThermo Fisher - issue of warrants
6th Feb 20187:00 amRNSPremaitha to attend key conferences in Middle East
5th Feb 20187:00 amRNSPremaitha's IONA test approved for sale in Brazil
24th Jan 20187:00 amRNSUK High Court grants right to appeal
22nd Jan 20187:00 amRNSSecured loan facility agreement with Thermo Fisher
29th Dec 20177:00 amRNSHalf Year Results
11th Dec 20177:00 amRNSPremaitha secures four further laboratories in EU
1st Dec 20179:40 amRNSPremaitha CEO Wins Outstanding Contribution Award
27th Nov 20177:00 amRNSMiddle East laboratory network expansion
23rd Nov 20177:00 amRNSPremaitha signs new partner in East Asia
21st Nov 201710:47 amRNSLitigation First Instance Judgment
30th Oct 201710:08 amRNSGrant of Share Options
24th Oct 20173:45 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Statement
13th Oct 20177:00 amRNSMiddle East Update
29th Sep 20177:04 amRNSFinal Results
29th Sep 20177:01 amRNSNotice of AGM
21st Sep 20174:05 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSPremaitha to offer NIPT in South Africa
7th Sep 20173:10 pmRNSFurther Patent Infringement Claims
29th Aug 20177:00 amRNSApproved for Good Manufacturing Process in Brazil
18th Jul 20172:02 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSInvestment Agreement Extension with Thermo Fisher
10th Jul 20177:00 amRNSPremaitha announces two laboratory hub contracts
3rd Jul 20177:00 amRNSLitigation Update
27th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSPremaitha launches Sage NIPT solution
5th Jun 20177:00 amRNSIndia Business Update
26th May 20177:00 amRNSIONA test validation on Thermo Fisher's Ion S5
19th May 20172:30 pmRNSPremaitha welcomes NIPT recommendation in France
16th May 20177:00 amRNSYear End Trading Update
12th May 20172:15 pmRNSUpdate Re. Swiss Customer
3rd Apr 20174:48 pmRNSHolding(s) in Company
31st Mar 20174:00 pmRNSSecond tranche of warrants issued to Thermo Fisher
17th Mar 20177:15 amRNSHardman Research: Expanding global distribution
13th Mar 20177:00 amRNSPremaitha to Attend International Medical Events
2nd Mar 201711:03 amRNSCompletion of Yourgene Acquisition
27th Feb 20177:00 amRNSCompletion of Acquisition
22nd Feb 20179:37 amRNSHolding(s) in Company
20th Feb 20177:00 amRNSMiddle East Business Update
16th Feb 20175:34 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSIssue of Equity
14th Feb 20179:32 amRNSHolding(s) in Company
13th Feb 20177:00 amRNSNew partnership with European diagnostics group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.